{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:07:44Z","timestamp":1789852064053,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.drup.2026.101476","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:58:35Z","timestamp":1789721915000},"page":"101476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nucleolar METTL16 drives ccRCC tumorigenesis and pazopanib resistance via translational activation of JAG1\/Notch signaling pathway"],"prefix":"10.1016","volume":"90","author":[{"given":"Zixuan","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6698-1549","authenticated-orcid":false,"given":"Hongfeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangbiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3533-9085","authenticated-orcid":false,"given":"Sichen","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuwu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101476_bib1","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.3390\/ijms25126328","article-title":"Metabolomics reveals tyrosine kinase inhibitor resistance-associated metabolic events in human metastatic renal cancer cells","volume":"25","author":"Amaro","year":"2024","journal-title":"IJMS"},{"key":"10.1016\/j.drup.2026.101476_bib2","doi-asserted-by":"crossref","first-page":"14786","DOI":"10.1021\/acs.jmedchem.4c01247","article-title":"Methyl-transferase-like protein 16 (METTL16): the intriguing journey of a key epitranscriptomic player becoming an emerging biological target","volume":"67","author":"Barone","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drup.2026.101476_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd4505","article-title":"Targeting the translation machinery in cancer","volume":"14","author":"Bhat","year":"2015","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.drup.2026.101476_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd3073","article-title":"Pazopanib","volume":"9","author":"Bukowski","year":"2010","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.drup.2026.101476_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s12276-025-01634-7","article-title":"CDK13 drives clear cell renal carcinoma through METTL16-mediated m6A modification of ACLY mRNA","volume":"58","author":"Chen","year":"2026","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.drup.2026.101476_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101776","article-title":"The promoting effect of the POU3F2\/METTL16\/PFKM cascade on glycolysis and tumorigenesis of hepatocellular carcinoma","volume":"30","author":"Chen","year":"2025","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.drup.2026.101476_bib7","doi-asserted-by":"crossref","first-page":"D1522","DOI":"10.1093\/nar\/gkab1081","article-title":"iProX in 2021: connecting proteomics data sharing with big data","volume":"50","author":"Chen","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2026.101476_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41420-023-01423-z","article-title":"Vascular mimicry induced by m6A mediated IGFL2-AS1\/AR axis contributes to pazopanib resistance in clear cell renal cell carcinoma","volume":"9","author":"Cheng","year":"2023","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.drup.2026.101476_bib9","doi-asserted-by":"crossref","first-page":"D28","DOI":"10.1093\/nar\/gkaf1172","article-title":"Database resources of the National Genomics Data Center, China National Center for Bioinformation in 2026","volume":"54","author":"CNCB-NGDC Members and Partners","year":"2026","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2026.101476_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s11658-022-00342-8","article-title":"METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner","volume":"27","author":"Dai","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.drup.2026.101476_bib11","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/ijms20051226","article-title":"Emerging role of eukaryote ribosomes in translational control","volume":"20","author":"Dalla Venezia","year":"2019","journal-title":"IJMS"},{"key":"10.1016\/j.drup.2026.101476_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/his.13735","article-title":"Grading of renal cell carcinoma","volume":"74","author":"Delahunt","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.drup.2026.101476_bib13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cell.2020.01.026","article-title":"Proteogenomic characterization of endometrial carcinoma","volume":"180","author":"Dou","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101476_bib14","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1200\/JCO.2013.50.8267","article-title":"Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study","volume":"32","author":"Escudier","year":"2014","journal-title":"JCO"},{"key":"10.1016\/j.drup.2026.101476_bib15","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.cell.2016.04.047","article-title":"Coexisting Liquid Phases Underlie Nucleolar Subcompartments","volume":"165","author":"Feric","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101476_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.stem.2022.12.006","article-title":"METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism","volume":"30","author":"Han","year":"2023","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.drup.2026.101476_bib17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1200\/JCO.2008.21.6994","article-title":"Efficacy and safety of Pazopanib in patients with metastatic renal cell carcinoma","volume":"28","author":"Hutson","year":"2010","journal-title":"JCO"},{"key":"10.1016\/j.drup.2026.101476_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.676","article-title":"Renal cancer: signaling pathways and advances in targeted therapies","volume":"5","author":"Jiang","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.drup.2026.101476_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.eururo.2025.06.005","article-title":"Epidemiology of renal cancer: incidence, mortality, survival, genetic predisposition, and risk factors","volume":"88","author":"Larcher","year":"2025","journal-title":"Eur. Urol."},{"key":"10.1016\/j.drup.2026.101476_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00018-024-05146-x","article-title":"METTL16 inhibits papillary thyroid cancer tumorigenicity through m6A\/YTHDC2\/SCD1-regulated lipid metabolism","volume":"81","author":"Li","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.drup.2026.101476_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112054","article-title":"GLI2\/Parkin-mediated mitophagy promotes pazopanib resistance in clear cell renal cell carcinoma","volume":"135","author":"Lin","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.drup.2026.101476_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118178","article-title":"A novel cinnamic acid derivative for hepatocellular carcinoma therapy by degrading METTL16 protein","volume":"124","author":"Liu","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drup.2026.101476_bib23","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1021\/jacsau.3c00832","article-title":"Aminothiazolone inhibitors disrupt the protein\u2013RNA interaction of METTL16 and modulate the m6A RNA modification","volume":"4","author":"Liu","year":"2024","journal-title":"JACS Au"},{"key":"10.1016\/j.drup.2026.101476_bib24","doi-asserted-by":"crossref","DOI":"10.34133\/research.0539","article-title":"STAT2\/SLC27A3\/PINK1-mediated mitophagy remodeling lipid metabolism contributes to pazopanib resistance in clear cell renal cell carcinoma","volume":"7","author":"Lu","year":"2024","journal-title":"Research"},{"key":"10.1016\/j.drup.2026.101476_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41568-025-00889-6","article-title":"N6-Methyladenosine: an RNA modification as a central regulator of cancer","volume":"26","author":"Luo","year":"2026","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101476_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41589-018-0184-3","article-title":"N6-methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation","volume":"15","author":"Ma","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.drup.2026.101476_bib27","doi-asserted-by":"crossref","first-page":"D1211","DOI":"10.1093\/nar\/gky869","article-title":"iProX: an integrated proteome resource","volume":"47","author":"Ma","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2026.101476_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13059-025-03497-7","article-title":"catGRANULE 2.0: accurate predictions of liquid-liquid phase separating proteins at single amino acid resolution","volume":"26","author":"Monti","year":"2025","journal-title":"Genome Biol."},{"key":"10.1016\/j.drup.2026.101476_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1303989","article-title":"Pazopanib versus sunitinib in metastatic renal-cell carcinoma","volume":"369","author":"Motzer","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2026.101476_bib30","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.62347\/DDRA7133","article-title":"IL-23 promotes PD-L1 expression and tumor immune evasion via METTL16 pathway","volume":"16","author":"Pan","year":"2026","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.drup.2026.101476_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc.2017.104","article-title":"Ribosome biogenesis in cancer: new players and therapeutic avenues","volume":"18","author":"Pelletier","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101476_bib32","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.cell.2017.05.003","article-title":"The U6 snRNA m6A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention","volume":"169","author":"Pendleton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101476_bib33","doi-asserted-by":"crossref","first-page":"13126","DOI":"10.3390\/ijms222313126","article-title":"Nucleolar Proteins and Non-Coding RNAs: Roles in Renal Cancer","volume":"22","author":"Pop\u0142awski","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.drup.2026.101476_bib34","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1016\/j.clgc.2019.01.018","article-title":"Real-world effectiveness and safety of Pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma","volume":"17","author":"Procopio","year":"2019","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.drup.2026.101476_bib35","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/nar\/gkl1172","article-title":"The structure and function of small nucleolar ribonucleoproteins","volume":"35","author":"Reichow","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2026.101476_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41586-020-2256-2","article-title":"Composition-dependent thermodynamics of intracellular phase separation","volume":"581","author":"Riback","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101476_bib37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41586-019-1374-1","article-title":"m6A enhances the phase separation potential of mRNA","volume":"571","author":"Ries","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101476_bib38","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S1470-2045(09)70240-2","article-title":"Resistance to targeted therapy in renal-cell carcinoma","volume":"10","author":"Rini","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2026.101476_bib39","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal cell carcinoma: a review","volume":"332","author":"Rose","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.drup.2026.101476_bib40","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1038\/s41598-018-23608-8","article-title":"Structural insights into the RNA methyltransferase domain of METTL16","volume":"8","author":"Ruszkowska","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2026.101476_bib41","doi-asserted-by":"crossref","first-page":"12198","DOI":"10.1021\/bi0492556","article-title":"Consequences of Binding an S -adenosylmethionine analogue on the structure and dynamics of the thiopurine methyltransferase protein backbone","volume":"43","author":"Scheuermann","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.drup.2026.101476_bib42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-023-05767-5","article-title":"Nucleolar URB1 ensures 3\u2032 ETS rRNA removal to prevent exosome surveillance","volume":"615","author":"Shan","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101476_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217698","article-title":"RNA methyltransferase METTL16: from molecular mechanisms to therapeutic prospects in cancers","volume":"624","author":"Shi","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2026.101476_bib44","doi-asserted-by":"crossref","DOI":"10.1177\/2041731420920597","article-title":"The anti-angiogenic tyrosine kinase inhibitor Pazopanib kills cancer cells and disrupts endothelial networks in biomimetic three-dimensional renal tumouroids","volume":"11","author":"Stamati","year":"2020","journal-title":"J. Tissue Eng."},{"key":"10.1016\/j.drup.2026.101476_bib45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1200\/JCO.2009.23.9764","article-title":"Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial","volume":"28","author":"Sternberg","year":"2010","journal-title":"JCO"},{"key":"10.1016\/j.drup.2026.101476_bib46","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","article-title":"Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101476_bib47","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/biology10080809","article-title":"SnoRNA in cancer progression, metastasis and immunotherapy response","volume":"10","author":"Van Der Werf","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.drup.2026.101476_bib48","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1093\/nar\/gkz619","article-title":"The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112","volume":"47","author":"van Tran","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2026.101476_bib49","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.18632\/aging.204980","article-title":"m6A methyltransferase METTL16 mediates immune evasion of colorectal cancer cells via epigenetically regulating PD-L1 expression","volume":"15","author":"Wang","year":"2023","journal-title":"Aging"},{"key":"10.1016\/j.drup.2026.101476_bib50","article-title":"METTL16 promotes translation and lung tumorigenesis by sequestering cytoplasmic eIF4E2","volume":"42","author":"Wang","year":"2023","journal-title":"Cell. Rep."},{"key":"10.1016\/j.drup.2026.101476_bib51","article-title":"Tumor-resident streptococcus pneumoniae promotes malignant progression and pazopanib resistance in clear cell renal cell carcinoma","author":"Wang","year":"2026","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101476_bib52","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41388-024-03003-6","article-title":"Downregulation of UBB potentiates SP1\/VEGFA-dependent angiogenesis in clear cell renal cell carcinoma","volume":"43","author":"Wang","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101476_bib53","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1111\/jcmm.16664","article-title":"METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer","volume":"25","author":"Wang","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.drup.2026.101476_bib54","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N6-methyladenosine Modulates Messenger RNA Translation Efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101476_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108495","article-title":"Hypoxia induces hepatocellular carcinoma metastasis via the HIF-1\u03b1\/METTL16\/lnc-CSMD1-7\/RBFOX2 axis","volume":"26","author":"Wang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.drup.2026.101476_bib56","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.15252\/embr.201744940","article-title":"Human METTL16 is a N6-methyladenosine (m6A) methyltransferase that targets pre-mRNAs and various non-coding RNAs","volume":"18","author":"Warda","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.drup.2026.101476_bib57","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2026.01.006","article-title":"RNA modifications in gene regulation: functions and pathways","volume":"189","author":"Wei","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101476_bib58","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13046-023-02732-y","article-title":"METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression","volume":"42","author":"Wei","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101476_bib59","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.7150\/ijbs.95375","article-title":"METTL16 Promotes Stability of SYNPO2L mRNA and leading to Cancer Cell Lung Metastasis by Secretion of COL10A1 and attract the Cancer-Associated Fibroblasts","volume":"20","author":"Wu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.drup.2026.101476_bib60","doi-asserted-by":"crossref","first-page":"15995","DOI":"10.1002\/anie.201807942","article-title":"An Elongation- and Ligation-Based qPCR amplification method for the radiolabeling-free detection of locus-specific N6 -methyladenosine modification","volume":"57","author":"Xiao","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.drup.2026.101476_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111952","article-title":"Unraveling m6A RNA methylation: from epitranscriptomics to therapeutic frontiers in renal cell carcinoma","volume":"134","author":"Xie","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.drup.2026.101476_bib62","article-title":"Multi-omics analysis reveals the role of ribosome biogenesis in malignant clear cell renal cell carcinoma and the development of a machine learning-based prognostic model","volume":"16","author":"Xie","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2026.101476_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2022.10.065","article-title":"METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis","volume":"638","author":"Ye","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drup.2026.101476_bib64","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.7150\/ijbs.86719","article-title":"METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway","volume":"20","author":"Yu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.drup.2026.101476_bib65","article-title":"Clinofibrate Disrupts the SNORA80B\/YTHDC1-Driven M6A modification to suppress cholesterol metabolism and cisplatin resistance in ESCC","volume":"13","author":"Yuan","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.drup.2026.101476_bib66","article-title":"The GSA Family in 2025: a broadened sharing platform for multi-omics and multimodal data","volume":"23","author":"Zhang","year":"2025","journal-title":"Genom. Proteom. Bioinforma."},{"key":"10.1016\/j.drup.2026.101476_bib67","article-title":"PDK1 elevation was induced by epigenetic modifications of KDM3A and METTL16 to mediate TKI resistance and cancer development","volume":"13","author":"Zhou","year":"2026","journal-title":"Genes. & Dis."},{"key":"10.1016\/j.drup.2026.101476_bib68","article-title":"Endothelial USP2a-METTL16 loop potentiates IL-6 signaling via m6A-mediated IL-6R stabilization in pulmonary vascular remodeling","author":"Zhu","year":"2026","journal-title":"Cell. Death Differ."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626001287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626001287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:53:23Z","timestamp":1789851203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626001287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":68,"alternative-id":["S1368764626001287"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101476","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nucleolar METTL16 drives ccRCC tumorigenesis and pazopanib resistance via translational activation of JAG1\/Notch signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101476"}}